Oct 1 (Reuters) - Mesoblast Ltd MSB.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ABOUT US FDA'S REVIEW OF ITS BIOLOGICS LICENSE APPLICATION FOR RYONCIL
Oct 1 (Reuters) - Mesoblast Ltd MSB.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ABOUT US FDA'S REVIEW OF ITS BIOLOGICS LICENSE APPLICATION FOR RYONCIL